48 Ken Griffin Pfizer Trades
Ken Griffin acquired 16M Pfizer shares worth $398M. That's 0.34% of their equity portfolio (42nd largest holding). The first Pfizer trade was made in Q2 2013. Since then Ken Griffin bought shares 65 more times and sold shares on 52 occasions. The investor's estimated purchase price is $597M, resulting in a loss of 33%.
Avg closing price
Price range
Increased shares by 111.3% (+7.83M shares)
Q2 2025
Avg closing price
$23.32
Price range
$21.59
-
$24.84
Sold 52.7% shares (-7.84M shares)
Q1 2025
Avg closing price
$26.17
Price range
$25.01
-
$27.13
Increased shares by 84.5% (+6.81M shares)
Q4 2024
Avg closing price
$27.11
Price range
$24.80
-
$30.19
Sold 60.5% shares (-12.3M shares)
Q3 2024
Avg closing price
$29.15
Price range
$27.70
-
$31.39
Increased shares by 63.0% (+7.89M shares)
Q2 2024
Avg closing price
$27.53
Price range
$25.26
-
$29.60
Increased shares by 7.6% (+879k shares)
Q1 2024
Avg closing price
$27.75
Price range
$25.89
-
$29.73
Increased shares by 408.5% (+9.34M shares)
Q4 2023
Avg closing price
$30.23
Price range
$26.13
-
$33.94
Increased shares by 7.6% (+162k shares)
Q3 2023
Avg closing price
$35.35
Price range
$32.09
-
$37.51
Increased shares by 39.4% (+601k shares)
Q2 2023
Avg closing price
$38.92
Price range
$36.12
-
$41.79
Increased shares by 27.7% (+331k shares)
Q1 2023
Avg closing price
$43.19
Price range
$39.39
-
$51.26
Sold 70.6% shares (-2.86M shares)
Q4 2022
Avg closing price
$47.94
Price range
$41.75
-
$54.48
Increased shares by 335.8% (+3.12M shares)
Q3 2022
Avg closing price
$48.59
Price range
$43.76
-
$53.42
Sold 34.9% shares (-499k shares)
Q2 2022
Avg closing price
$50.96
Price range
$46.53
-
$55.17
Increased shares by 45.5% (+447k shares)
Q1 2022
Avg closing price
$51.89
Price range
$45.75
-
$56.69
Sold 81.5% shares (-4.34M shares)
Q4 2021
Avg closing price
$49.55
Price range
$41.32
-
$61.25
Increased shares by 649.6% (+4.61M shares)
Q3 2021
Avg closing price
$44.30
Price range
$39.25
-
$50.42
Sold 91.3% shares (-7.45M shares)
Q2 2021
Avg closing price
$38.89
Price range
$35.91
-
$40.68
Increased shares by 593.0% (+6.98M shares)
Q1 2021
Avg closing price
$35.51
Price range
$33.49
-
$37.77
Increased shares by 0.3% (+3.69k shares)
Q3 2020
Avg closing price
$36.95
Price range
$33.46
-
$39.26
Sold 85.6% shares (-7M shares)
Q2 2020
Avg closing price
$35.81
Price range
$31.75
-
$38.51
News about Pfizer Inc. and Ken Griffin
Do Billionaires Israel Englander and Ken Griffin Know Something? Each Just Bought This Plagued Value Stock.
Hedge funds managed by Israel Englander and Ken Griffin both scooped up shares in a troubled pharmaceutical stock last quarter.
Billionaire Ken Griffin Just Bought 7.9 Million Shares of This Beaten-Down Pharmaceutical Stock as It Eyes the Weight Loss Market
Ken Griffin's Citadel continues to add to its position in Pfizer.